Breckenridge Pharmaceutical, Inc Pharmaceutical Import Profile — United States (DGFT 2022–2026)

Name: Breckenridge Pharmaceutical, Inc Pharmaceutical Import Records from India — 3 Products, $4.4M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Breckenridge Pharmaceutical, Inc — Pharmaceutical Importer Profile (2026) | 3 Products, $4.4M Trade | TransData Nexus

Breckenridge Pharmaceutical, Inc

Pharmaceutical Importer · United States · Immunosuppressants Focus · $4.4M Total Trade · DGFT Verified

Breckenridge Pharmaceutical, Inc is a pharmaceutical importer based in United States with a total trade value of $4.4M across 3 products in 2 therapeutic categories. Based on 89 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. Breckenridge Pharmaceutical, Inc sources from 1 verified Indian supplier, with Natco Pharma Limited accounting for 100.0% of imports.

Breckenridge Pharmaceutical, Inc — Import Portfolio & Supplier Network

Breckenridge Pharmaceutical, Inc import network — 3 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Breckenridge Pharmaceutical, Inc?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Natco Pharma Limited	$1.2M	31	100.0%

Breckenridge Pharmaceutical, Inc sources from 1 verified Indian supplier across 31 distinct formulations. The sourcing is highly concentrated — Natco Pharma Limited accounts for 100.0% of total imports, indicating a strategic single-source relationship.

Formulation	Value	Ships
Granisetron 1MG hcl tablets 2x10's	$50.0K	1
Erlotinib 150MG tablets 30's (other	$50.0K	1
Rizatriptan odt 10MG tablets 18's	$50.0K	1
Rizatriptan odt 10MG tablets 18's	$50.0K	1
Rizatriptan odt 10MG tablets 18's	$50.0K	1
Everolimus 7.5 MG tablets 30's (802 x 30's) (appendix 4r, rodtep entry no:10112)(our reference(s) ci no:124228)	$50.0K	1
Everolimus 10 MG tablets 28's (921 x 28's) (appendix 4r, rodtep entry no:10112)(our reference(s) ci no:124251)	$50.0K	1
Everolimus 7.5 MG tablets 28's (1242 x 28's) (appendix 4r, rodtep entry no:10112)(our reference(s) ci no:124251)	$50.0K	1
Everolimus 10 MG tablets 28's (1833 x 28's) (appendix 4r, rodtep entry no:10112)(our reference(s) ci no:124266)	$50.0K	1
Everolimus 10 MG tablets 30's (552 x 30's) (appendix 4r, rodtep entry no:10112)(our reference(s) ci no:124283)	$50.0K	1
Everolimus 5 MG tablets 28's (1896 x 28's) (appendix 4r, rodtep entry no:10112)(our reference(s) ci no:124283)	$50.0K	1
Everolimus 0.5 MG tablets 60's (7350 x 60's) (appendix 4r, rodtep entry no:10112)(our reference(s) ci no:124284)	$50.0K	1
Everolimus 0.75 MG tablets 60's (3414 x60's) (appendix 4r, rodtep entry no:10112)(our reference(s) ci no:124284)	$50.0K	1
Everolimus 10 MG tablets 28's (618 x 28's) (appendix 4r, rodtep entry no:10112)(our reference(s) ci no:124295)	$50.0K	1
Everolimus 10 MG tablets 28's (921 x 28's) (appendix 4r, rodtep entry no:10112)(our reference(s) ci no:125009)	$50.0K	1

Import Portfolio — Top 3 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Everolimus	Immunosuppressants	$4.2M	84	8.3%	3
2	Anastrozole	Advanced Oncology	$150.0K	3	0.1%	5
3	Erlotinib	Advanced Oncology	$91.2K	2	3.4%	7

Breckenridge Pharmaceutical, Inc imports 3 pharmaceutical products across 2 categories into United States totaling $4.4M.

Breckenridge Pharmaceutical, Inc — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Breckenridge Pharmaceutical, Inc. is a privately held pharmaceutical company headquartered in Berkeley Heights, New Jersey. Established in 1983, the company specializes in the development, marketing, and distribution of high-quality, cost-effective generic drugs across the United States. As the American affiliate of Towa International, based in Barcelona, Spain, Breckenridge leverages its global network to source and deliver a diverse portfolio of pharmaceutical products.

The company's product range encompasses over 70 items, including tablets, capsules, liquids, suspensions, ophthalmics, nasal sprays, powders, and injectables. Breckenridge's strategic approach involves both organic development and partnerships with manufacturers worldwide, ensuring a stable supply and adherence to the highest quality standards. This commitment aims to improve healthcare resilience and provide equitable access to medical services for all.

2Distribution Network

Breckenridge Pharmaceutical operates a comprehensive distribution network within the United States, ensuring nationwide availability of its products. While specific warehouse locations and logistics capabilities are not publicly detailed, the company's extensive reach is facilitated through strategic partnerships and a robust supply chain infrastructure. This network enables efficient delivery to various stakeholders, including wholesalers, distributors, retail pharmacies, and managed care facilities.

3Industry Role

In the U.S. pharmaceutical supply chain, Breckenridge Pharmaceutical functions primarily as a pharmaceutical importer and distributor. By sourcing generic medications from global manufacturers, including those in India, the company plays a pivotal role in enhancing the availability of affordable and high-quality drugs. Breckenridge's operations support a diverse range of healthcare providers, contributing to the overall efficiency and accessibility of the pharmaceutical market.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Breckenridge Pharmaceutical, Inc

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Breckenridge Pharmaceutical's sourcing strategy exhibits a high degree of concentration, with a significant portion of its imports originating from a single supplier, NATCO Pharma Limited. This dependency, while potentially offering benefits such as favorable pricing and streamlined logistics, also introduces risks related to supply chain disruptions and regulatory changes affecting the supplier. The company's reliance on a single supplier underscores the importance of maintaining a stable and compliant relationship to ensure uninterrupted product availability.

2Supply Chain Resilience

The resilience of Breckenridge Pharmaceutical's supply chain is closely tied to its partnership with NATCO Pharma Limited. While the company imports a diverse range of formulations, the heavy reliance on a single supplier may pose challenges in the event of production issues, regulatory changes, or geopolitical tensions. To mitigate these risks, it is essential for Breckenridge to establish contingency plans, including identifying alternative suppliers and diversifying its sourcing strategy. Ensuring that all suppliers adhere to Good Manufacturing Practice (GMP) standards is crucial for maintaining product quality and regulatory compliance.

Strategic Implications

Importing Pharmaceuticals into United States — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for United States

1Regulatory Authority & Framework

In the United States, the Food and Drug Administration (FDA) serves as the primary regulatory authority overseeing the approval and monitoring of pharmaceutical products. Key legislation governing pharmaceutical imports includes the Federal Food, Drug, and Cosmetic Act, which sets forth requirements for drug safety, efficacy, and quality. The FDA's approval process for generic drugs involves the submission of an Abbreviated New Drug Application (ANDA), demonstrating that the generic product is bioequivalent to its branded counterpart. For Indian generics to enter the U.S. market, they must comply with FDA regulations, including obtaining ANDA approval and adhering to GMP standards.

2Import Licensing & GMP

Import licensing requirements for pharmaceutical products entering the U.S. market are stringent. Manufacturers must obtain ANDA approval from the FDA, which involves demonstrating that the generic product is bioequivalent to its branded version. Additionally, the FDA requires that foreign manufacturing facilities comply with U.S. GMP standards, which may include certifications such as EU GMP, WHO GMP, or PIC/S. Wholesale distributors like Breckenridge Pharmaceutical must also obtain appropriate licenses to operate within the U.S., ensuring that all imported products meet the necessary regulatory and quality standards.

Breckenridge Pharmaceutical, Inc — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Breckenridge Pharmaceutical's focus on importing immunosuppressants and advanced oncology drugs aligns with the growing demand for affordable treatments in these therapeutic areas. The substantial import value of Everolimus, a key immunosuppressant, indicates a strategic emphasis on this category. The company's product strategy is driven by the need to provide cost-effective solutions for complex medical conditions, thereby improving patient access to essential therapies.

2Sourcing Profile

Breckenridge Pharmaceutical's sourcing strategy for generic drugs involves partnerships with manufacturers worldwide, including those in India. The company's focus on finished pharmaceutical formulations, rather than raw active pharmaceutical ingredients (APIs), allows for greater control over product quality and compliance with U.S. regulatory standards. India's established pharmaceutical manufacturing capabilities make it a key partner in Breckenridge's procurement strategy, contributing to the company's ability to offer a diverse and reliable product portfolio.

3Market Positioning

Breckenridge Pharmaceutical serves a broad segment of the U.S. pharmaceutical market, including retail pharmacies, hospital systems, and managed care facilities. By providing a range of generic medications, the company supports various healthcare providers in delivering cost-effective treatments to patients. Its strategic focus on therapeutic areas with high unmet needs, such as immunosuppressants and oncology, positions Breckenridge as a valuable partner in enhancing patient access to essential therapies.

Seller's Guide — How to Become a Supplier to Breckenridge Pharmaceutical, Inc

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to collaborate with Breckenridge Pharmaceutical, particularly in the areas of immunosuppressants and oncology drugs. By offering high-quality, GMP-compliant finished formulations, Indian exporters can meet the specific needs of Breckenridge's product portfolio. Establishing such partnerships would require a clear understanding of regulatory requirements, quality standards, and the ability to meet the demand for cost-effective, reliable pharmaceutical products.

2Requirements & Qualifications

Indian exporters seeking to supply Breckenridge Pharmaceutical must ensure that their manufacturing facilities comply with U.S. GMP standards, which may include certifications such as EU GMP, WHO GMP, or PIC/S. Products must undergo batch testing to meet FDA quality standards and adhere to labeling requirements, including English language labeling and serialization mandates. Additionally, exporters must navigate the FDA's ANDA approval process, demonstrating bioequivalence to branded products.

3How to Approach

Frequently Asked Questions — Breckenridge Pharmaceutical, Inc

What products does Breckenridge Pharmaceutical, Inc import from India?

Breckenridge Pharmaceutical, Inc imports 3 pharmaceutical products across 2 categories. Top imports: Everolimus ($4.2M), Anastrozole ($150.0K), Erlotinib ($91.2K).

Who supplies pharmaceuticals to Breckenridge Pharmaceutical, Inc from India?

Breckenridge Pharmaceutical, Inc sources from 1 verified Indian suppliers. The primary supplier is Natco Pharma Limited (100.0% of imports, $1.2M).

What is Breckenridge Pharmaceutical, Inc's total pharmaceutical import value?

Breckenridge Pharmaceutical, Inc's total pharmaceutical import value from India is $4.4M, based on 89 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Breckenridge Pharmaceutical, Inc focus on?

Breckenridge Pharmaceutical, Inc imports across 2 categories. The largest: Immunosuppressants (94.6%), Advanced Oncology (5.4%).

Get Full Breckenridge Pharmaceutical, Inc Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Profile aggregates 2 company name variants from customs records. For current shipment-level data, contact TransData Nexus.